These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2748536)

  • 1. In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase.
    Smith EW; Haigh JM
    Pharm Res; 1989 May; 6(5):431-5. PubMed ID: 2748536
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay of betamethasone 17-valerate and its degradation products.
    Li Wan Po A; Irwin WJ; Yip YW
    J Chromatogr; 1979 Sep; 176(3):399-405. PubMed ID: 546923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stability of betamethasone-17-valerate in semi-solid bases.
    Yip YW; Po LW
    J Pharm Pharmacol; 1979 Jun; 31(6):400-2. PubMed ID: 39141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and degradation of betamethasone 17-valerate in homogenized living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    Dermatology; 1994; 188(1):13-7. PubMed ID: 8305748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability indicating liquid chromatographic method for simultaneous quantification of betamethasone valerate and tazarotene in in vitro and ex vivo studies of complex nanoformulation.
    Rapalli VK; Singhvi G; Gorantla S; Waghule T; Dubey SK; Saha RN; Hasnain MS; Nayak AK
    J Sep Sci; 2019 Nov; 42(22):3413-3420. PubMed ID: 31529758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a novel stability-indicating HPLC method for the simultaneous assay of betamethasone-17-valerate, fusidic acid, potassium sorbate, methylparaben and propylparaben in a topical cream preparation.
    Byrne J; Velasco-Torrijos T; Reinhardt R
    J Pharm Biomed Anal; 2014 Aug; 96():111-7. PubMed ID: 24731970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous HPLC Determination of Betamethasone Esters-Containing Mixtures: Analysis of Their Topical Preparations.
    Hassib ST; Mahrouse MA; Elkady EF; Sayed RM
    J Chromatogr Sci; 2018 Sep; 56(8):716-723. PubMed ID: 29800112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid reversed-phase high-performance liquid chromatographic analysis of steroid products.
    Burgess C
    J Chromatogr; 1978 Feb; 149():233-40. PubMed ID: 649732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an UHPLC method for the determination of betamethasone valerate in cream, gel, ointment and lotion.
    Solon LG; Lima IP; Nogueira FH; de Araújo JP; Vivacqua CA; Aragão CF
    Steroids; 2016 Feb; 106():70-7. PubMed ID: 26708266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Betamethasone valerate reference standard (Control 941) of the National Institute of Health Sciences].
    Kitajima A; Tanimoto T; Okada S
    Eisei Shikenjo Hokoku; 1995; (113):111-3. PubMed ID: 8717241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream.
    Magnus AD; Haigh JM; Kanfer I
    Dermatologica; 1981; 163(4):331-7. PubMed ID: 7308554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
    Ryatt KS; Cotterill JA; Mehta A
    J Clin Hosp Pharm; 1983 Jun; 8(2):143-5. PubMed ID: 6875011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.
    Shah VP; Elkins J; Skelly JP
    J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro diffusion cell design and validation. II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation.
    Smith EW; Haigh JM
    Acta Pharm Nord; 1992; 4(3):171-8. PubMed ID: 1418642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Determination of Cinchocaine Hydrochloride and Betamethasone Valerate in Presence of Their Degradation Products.
    Fayed AS; Rezk MR; Marzouk HM; Abbas SS
    J Chromatogr Sci; 2017 May; 55(5):518-527. PubMed ID: 28168304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of norethindrone stability on red delicious apples.
    Mayberry DO; Kowblansky M; Lane PA; Wray PE
    J Pharm Sci; 1990 Aug; 79(8):746-9. PubMed ID: 2231340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of glucocorticoids by liquid chromatography. III. Application to ointments and a cream containing cortisone acetate, dexamethasone acetate, fluorometholone, and betamethasone valerate.
    Tokunaga H; Kimura T; Kawamura J
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4012-6. PubMed ID: 6529797
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of betamethasone 17-benzoate in lipophylic vehicles by reversed-phase high-performance liquid chromatography.
    Maron N; Cristi EA; Ramos AA
    J Pharm Sci; 1988 Jul; 77(7):638-9. PubMed ID: 3171954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.